These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2387553)

  • 21. Meizothrombin formation during factor Xa-catalyzed prothrombin activation. Formation in a purified system and in plasma.
    Tans G; Janssen-Claessen T; Hemker HC; Zwaal RF; Rosing J
    J Biol Chem; 1991 Nov; 266(32):21864-73. PubMed ID: 1939210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction.
    Krishnaswamy S; Mann KG; Nesheim ME
    J Biol Chem; 1986 Jul; 261(19):8977-84. PubMed ID: 3755135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of prothrombin in the presence of human umbilical-vein endothelial cells.
    Schoen P; Reutelingsperger C; Lindhout T
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):661-4. PubMed ID: 1531589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface.
    Kazama Y; Komiyama Y; Kisiel W
    Blood; 1993 Feb; 81(3):676-82. PubMed ID: 8381308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prothrombotic skeletal muscle myosin directly enhances prothrombin activation by binding factors Xa and Va.
    Deguchi H; Sinha RK; Marchese P; Ruggeri ZM; Zilberman-Rudenko J; McCarty OJT; Cohen MJ; Griffin JH
    Blood; 2016 Oct; 128(14):1870-1878. PubMed ID: 27421960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procoagulant properties of human MV3 melanoma cells.
    Geaquinto DL; Fernandes RS; Lima LG; Barja-Fidalgo C; Monteiro RQ
    Braz J Med Biol Res; 2008 Feb; 41(2):99-105. PubMed ID: 18235964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.
    Ofosu FA; Lormeau JC; Craven S; Dewar L; Anvari N
    Thromb Haemost; 1994 Dec; 72(6):862-8. PubMed ID: 7740455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets.
    Sugo T; Nakamikawa C; Tanabe S; Matsuda M
    J Biochem; 1995 Feb; 117(2):244-50. PubMed ID: 7608107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The factor Xa-catalyzed activation of factor V.
    Foster WB; Nesheim ME; Mann KG
    J Biol Chem; 1983 Nov; 258(22):13970-7. PubMed ID: 6643460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation factor V: a plethora of anticoagulant molecules.
    Kalafatis M
    Curr Opin Hematol; 2005 Mar; 12(2):141-8. PubMed ID: 15725905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous flow and the prothrombinase-catalyzed activation of prothrombin.
    Schoen P; Lindhout T; Willems G; Hemker HC
    Thromb Haemost; 1990 Dec; 64(4):542-7. PubMed ID: 2084939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prothrombin conversion under flow conditions by prothrombinase assembled on adherent platelets.
    Billy D; Briedé J; Heemskerk JW; Hemker HC; Lindhout T
    Blood Coagul Fibrinolysis; 1997 Apr; 8(3):168-74. PubMed ID: 9167017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an inducible endothelial cell prothrombin activator.
    Liu L; Rodgers GM
    Blood; 1996 Oct; 88(8):2989-94. PubMed ID: 8874196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of factor Xa-mediated procoagulant activity of human lung fibroblasts and pleural mesothelial cells.
    Kumar A; Koenig KB; Johnson AR; Fair DS; Idell S
    Eur Respir J; 1995 Dec; 8(12):2038-45. PubMed ID: 8666098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes.
    Wu JR; Zhou C; Majumder R; Powers DD; Weinreb G; Lentz BR
    Biochemistry; 2002 Jan; 41(3):935-49. PubMed ID: 11790117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RANKL induces components of the extrinsic coagulation pathway in osteoclasts.
    Karlström E; Ek-Rylander B; Wendel M; Andersson G
    Biochem Biophys Res Commun; 2010 Apr; 394(3):593-9. PubMed ID: 20214889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of human prothrombin by the venom of Lonomia achelous (Cramer) caterpillars.
    Guerrero B; Arocha-Piñango CL
    Thromb Res; 1992 May; 66(2-3):169-77. PubMed ID: 1412190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simulation model for thrombin generation in plasma.
    Willems GM; Lindhout T; Hermens WT; Hemker HC
    Haemostasis; 1991; 21(4):197-207. PubMed ID: 1794746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.